128 related articles for article (PubMed ID: 19293355)
21. Randomized pilot trial between prostaglandin I2 analog and anti-platelet drugs on peripheral arterial disease in hemodialysis patients.
Ohtake T; Sato M; Nakazawa R; Kondoh M; Miyaji T; Moriya H; Hidaka S; Kobayashi S
Ther Apher Dial; 2014 Feb; 18(1):1-8. PubMed ID: 24499078
[TBL] [Abstract][Full Text] [Related]
22. Effects of celecoxib on high-sensitivity C-reactive protein in chronic peritoneal dialysis patients.
Kim SB; Kim SH; Chang JW; Lee SK; Min WK; Chi HS; Park JS
Ren Fail; 2004 Jul; 26(4):381-4. PubMed ID: 15462105
[TBL] [Abstract][Full Text] [Related]
23. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
24. Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients.
Hassan KS; Hassan SK; Hijazi EG; Khazim KO
Ren Fail; 2010; 32(9):1031-5. PubMed ID: 20863205
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
[TBL] [Abstract][Full Text] [Related]
26. Beraprost sodium versus clopidogrel for preventing vascular thromboembolic events of arteriovenous fistula in uraemic patients: a retrospective study with a mean 3-year follow-up.
Wan Z; Zhu Y; Yang R; Zhang Y; Yang C; Cao L; Yan W; Wang Q; Li N; Zhao M; Gui K; Xiong M
J Int Med Res; 2019 Jan; 47(1):252-264. PubMed ID: 30270798
[TBL] [Abstract][Full Text] [Related]
27. Effect of beraprost sodium, a stable prostaglandin I2 analogue, on platelet aggregation in diabetes mellitus.
Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
Int J Clin Pharmacol Res; 1996; 16(4-5):99-102. PubMed ID: 9172007
[TBL] [Abstract][Full Text] [Related]
28. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H
Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
[TBL] [Abstract][Full Text] [Related]
29. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
[TBL] [Abstract][Full Text] [Related]
30. Effects of oral beraprost sodium, a prostaglandin I2 analogue, on endothelium dependent vasodilatation in the forearm of patients with coronary artery disease.
Ohata S; Ishibashi Y; Shimada T; Takahashi N; Sugamori T; Sakane T; Hirano Y; Oyake N; Murakami Y; Higami T
Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):381-7. PubMed ID: 16620305
[TBL] [Abstract][Full Text] [Related]
31. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
32. Effects of the prostaglandin I2 analogue, beraprost sodium, on vascular cell adhesion molecule-1 expression in human vascular endothelial cells and circulating vascular cell adhesion molecule-1 level in patients with type 2 diabetes mellitus.
Goya K; Otsuki M; Xu X; Kasayama S
Metabolism; 2003 Feb; 52(2):192-8. PubMed ID: 12601631
[TBL] [Abstract][Full Text] [Related]
33. Effect of a prostaglandin I2 analogue, beraprost sodium, on burn-induced gastric mucosal injury in rats.
Battal MN; Hata Y; Matsuka K; Ito O; Matsuda H; Yoshida Y; Kawazoe T; Nagao M
Burns; 1997 May; 23(3):232-7. PubMed ID: 9232284
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive study on hemostasis in CAPD patients treated with erythropoietin.
Malyszko J; Suchowierska E; Malyszko JS; Mysliwiec M
Perit Dial Int; 2002; 22(5):582-92. PubMed ID: 12455569
[TBL] [Abstract][Full Text] [Related]
35. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response.
Borawski J; Naumnik B; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2001 Jul; 16(7):1442-7. PubMed ID: 11427638
[TBL] [Abstract][Full Text] [Related]
36. Amelioration by beraprost sodium, a prostacyclin analogue, of established renal dysfunction in rat glomerulonephritis model.
Yamada M; Sasaki R; Sato N; Suzuki M; Tamura M; Matsushita T; Kurumatani H
Eur J Pharmacol; 2002 Aug; 449(1-2):167-76. PubMed ID: 12163121
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of livedo vasculitis with beraprost sodium: a possible mechanism of thrombomodulin upregulation.
Tsutsui K; Shirasaki F; Takata M; Takehara K
Dermatology; 1996; 192(2):120-4. PubMed ID: 8829492
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of beraprost sodium on Raynaud's phenomenon in patients with systemic sclerosis].
Kaburaki J; Kuwana M; Akizuki M; Takano M; Tojo T
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Feb; 18(1):29-35. PubMed ID: 7553036
[TBL] [Abstract][Full Text] [Related]
39. A stable prostacyclin analog, beraprost sodium, attenuates platelet accumulation and preservation-reperfusion injury of isografts in a rat model of lung transplantation.
Okada Y; Marchevsky AM; Kass RM; Matloff JM; Jordan SC
Transplantation; 1998 Nov; 66(9):1132-6. PubMed ID: 9825806
[TBL] [Abstract][Full Text] [Related]
40. [Research and development of beraprost sodium, a new stable PGI2 analogue].
Nishio S; Nagase H; Kanou K; Aoki S; Kanbayashi Y
Yakugaku Zasshi; 1997 Aug; 117(8):509-21. PubMed ID: 9306726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
